Related Experiment Video
Updated: Mar 24, 2026

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle
Published on: November 4, 2011
PEG/Folic Acid Coloaded Er:Y2O3 Upconversion Nanoparticles: Enhanced Internalization and Potential for High-Contrast
Ester Butera1, Regina Maria Chiechio2, Angela Caponnetto3
1Dipartimento di Scienze del Farmaco, Università di Catania, Via Santa Sofia 64, Catania 95125 Italy.
Abstract:
Erbium-doped yttrium oxide nanoparticles (Er:Y2O3 NPs) with a log-normal size distribution peaking at 43 nm were synthesized and coloaded with PEG and folic acid (FA) to achieve tumor cell targeting while maintaining good water dispersibility. Structural and optical analyses (TEM, FTIR, PL, upconversion) confirmed successful functionalization without significant alterations in the fluorescence signal. In colorectal cancer cells (HCT-116), MTT assays showed >80% viability for concentrations of NPs between 0.1 and 1 μg/mL, indicating low cytotoxicity. Confocal microscopy revealed fluorescence signals consistent with potential nanoparticle internalization, although contrast was limited by cellular autofluorescence. ICP-OES quantification supported greater internalization of PEG-FA nanoparticles compared to PEG nanoparticles, confirming the role of FA in enhancing internalization. Moreover, NIR excitation (980 nm) suppressed cellular autofluorescence, suggesting the potential of these nanoparticles for high-contrast bioimaging applications.

